Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

AGE

AgeX Therapeutics (AGE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AGE
DataOraFonteTitoloSimboloCompagnia
22/03/202422:27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/03/202422:49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
07/03/202422:47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
07/03/202413:47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
14/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
18/01/202423:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
16/01/202415:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
15/11/202315:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
14/11/202322:05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/11/202322:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
22/09/202322:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AGEAgeX Therapeutics Inc
30/08/202313:00Business WireSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAMEX:AGEAgeX Therapeutics Inc
14/08/202322:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AGEAgeX Therapeutics Inc
14/08/202322:05Business WireAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
25/07/202300:28Business WireAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
21/07/202323:32Business WireAgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
08/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AGEAgeX Therapeutics Inc
23/05/202322:05Business WireAgeX Therapeutics Announces Appeal of NYSE American DeterminationAMEX:AGEAgeX Therapeutics Inc
18/05/202322:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AGEAgeX Therapeutics Inc
12/05/202322:05Business WireAgeX Therapeutics Reports First Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
26/04/202322:05Business WireAgeX Therapeutics Receives Stock Exchange Deficiency LetterAMEX:AGEAgeX Therapeutics Inc
31/03/202322:05Business WireAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
22/03/202321:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AGEAgeX Therapeutics Inc
22/03/202321:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:AGEAgeX Therapeutics Inc
06/02/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:AGEAgeX Therapeutics Inc
25/11/202221:41Business WireAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsAMEX:AGEAgeX Therapeutics Inc
10/11/202222:21Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AGEAgeX Therapeutics Inc
10/11/202222:05Business WireAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
02/11/202221:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AGEAgeX Therapeutics Inc
05/10/202222:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:AGEAgeX Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AGE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network